Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ TACE
TACE
14 registered clinical trials studyying TACE —
9 currently recruiting
.
Status
Trial
Sponsor
Phase
Not Yet Recruiting
Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellula
NCT07417800
Second Affiliated Hospital, School of Medicine, Zhejiang University
N/A
Not Yet Recruiting
H101 Plus TACE for r/m HNSCC
NCT07398664
West China Hospital
Phase 2
Recruiting
DEB-TACE vs cTACE in HCC After TIPS
NCT07322848
First Affiliated Hospital, Sun Yat-Sen University
Phase 3
Not Yet Recruiting
Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment
NCT07168668
Chang Gung Memorial Hospital
Phase 2
Not Yet Recruiting
A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With
NCT07128251
Anhui Provincial Hospital
Phase 2
Recruiting
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
NCT07186621
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
Active Not Recruiting
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Can
NCT07230080
Nanfang Hospital, Southern Medical University
—
Not Yet Recruiting
Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization f
NCT06483594
Shengjing Hospital
—
Recruiting
Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable
NCT05970666
The First Affiliated Hospital of Xiamen University
Phase 2
Recruiting
Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage I
NCT05920863
Zhejiang Cancer Hospital
Phase 2
Unknown
Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizuma
NCT05131698
Cancer Hospital of Guangxi Medical University
EARLY_Phase 1
Unknown
Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence
NCT04213118
First Affiliated Hospital Xi'an Jiaotong University
Phase 2
Completed
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
NCT02724358
Eastern Hepatobiliary Surgery Hospital
N/A
Unknown
Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation
NCT01415063
Sun Yat-sen University
Phase 4